These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 30116405

  • 1. Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.
    Więcek S, Chudek J, Woś H, Bożentowicz-Wikarek M, Kordys-Darmolinska B, Grzybowska-Chlebowczyk U.
    Dis Markers; 2018; 2018():5940893. PubMed ID: 30116405
    [Abstract] [Full Text] [Related]

  • 2. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
    Ellemunter H, Engelhardt A, Schüller K, Steinkamp G.
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476
    [Abstract] [Full Text] [Related]

  • 3. Intestinal inflammation and impact on growth in children with cystic fibrosis.
    Dhaliwal J, Leach S, Katz T, Nahidi L, Pang T, Lee JM, Strachan R, Day AS, Jaffe A, Ooi CY.
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
    [Abstract] [Full Text] [Related]

  • 4. Evidence for a Cystic Fibrosis Enteropathy.
    Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC.
    PLoS One; 2015 Apr; 10(10):e0138062. PubMed ID: 26484665
    [Abstract] [Full Text] [Related]

  • 5. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L, Aksnes L, Fluge G.
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [Abstract] [Full Text] [Related]

  • 6. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
    Roca M, Masip E, Colombo C, Boon M, Hulst JM, Garriga M, de Koning BAE, Bulfamante A, de Boeck K, Ribes-Koninckx C, Calvo-Lerma J.
    Arch Dis Child; 2024 Jun 19; 109(7):552-556. PubMed ID: 38123920
    [Abstract] [Full Text] [Related]

  • 7. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
    Parisi GF, Papale M, Rotolo N, Aloisio D, Tardino L, Scuderi MG, Di Benedetto V, Nenna R, Midulla F, Leonardi S.
    Immunobiology; 2017 Mar 19; 222(3):582-586. PubMed ID: 28012584
    [Abstract] [Full Text] [Related]

  • 8. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR, Forstner GG, Gaskin KJ, Moore DJ, Cleghorn GJ, Wong SS, Corey ML.
    Pediatr Res; 1986 Mar 19; 20(3):209-13. PubMed ID: 3703609
    [Abstract] [Full Text] [Related]

  • 9. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
    López-Neyra A, Suárez L, Muñoz M, de Blas A, Ruiz de Valbuena M, Garriga M, Calvo J, Ribes C, Girón Moreno R, Máiz L, González D, Bousoño C, Manzanares J, Pastor Ó, Martínez-Botas J, Del Campo R, Cantón R, Roy G, Menacho M, Arroyo D, Zamora J, Soriano JB, Lamas A.
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov 19; 162():102186. PubMed ID: 33038833
    [Abstract] [Full Text] [Related]

  • 10. Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis.
    Walkowiak J, Nousia-Arvanitakis S, Lisowska A, Piotrowski R, Strzykala K, Bychowiec B, Songin T, Galli-Tsinopoulou A, Sands D, Pidonia I, Krawczynski M, Milanowski A, Herzig KH.
    J Pediatr Gastroenterol Nutr; 2004 Apr 19; 38(4):430-5. PubMed ID: 15085023
    [Abstract] [Full Text] [Related]

  • 11. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A, Madry E, Pogorzelski A, Szydłowski J, Radzikowski A, Walkowiak J.
    Scand J Clin Lab Invest; 2010 Sep 19; 70(5):322-6. PubMed ID: 20560844
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
    Walkowiak J, Herzig KH, Strzykala K, Lisowska A, Przyslawski J, Grzymislawski M, Krawczynski M.
    Med Wieku Rozwoj; 2003 Sep 19; 7(2):149-55. PubMed ID: 12878785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T, Leach ST, Katz T, Jaffe A, Day AS, Ooi CY.
    J Gastroenterol Hepatol; 2015 May 19; 30(5):866-71. PubMed ID: 25376228
    [Abstract] [Full Text] [Related]

  • 15. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
    Calvo-Lerma J, Roca M, Boon M, Colombo C, de Koning B, Fornés-Ferrer V, Masip E, Garriga M, Bulfamante A, Asensio-Grau A, Andrés A, de Boeck K, Hulst J, Ribes-Koninckx C.
    Pediatr Res; 2021 Jan 19; 89(1):205-210. PubMed ID: 32247283
    [Abstract] [Full Text] [Related]

  • 16. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr 19; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 17. Faecal elastase 1: a marker of exocrine pancreatic insufficiency in cystic fibrosis.
    Phillips IJ, Rowe DJ, Dewar P, Connett GJ.
    Ann Clin Biochem; 1999 Nov 19; 36 ( Pt 6)():739-42. PubMed ID: 10586310
    [Abstract] [Full Text] [Related]

  • 18. Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.
    Pezzilli R, Barassi A, Morselli-Labate AM, Fantini L, Tomassetti P, Campana D, Casadei R, Finazzi S, d'Eril GM, Corinaldesi R.
    J Gastroenterol; 2007 Sep 19; 42(9):754-60. PubMed ID: 17876545
    [Abstract] [Full Text] [Related]

  • 19. Calprotectin in cystic fibrosis.
    Rumman N, Sultan M, El-Chammas K, Goh V, Salzman N, Quintero D, Werlin S.
    BMC Pediatr; 2014 May 29; 14():133. PubMed ID: 24885444
    [Abstract] [Full Text] [Related]

  • 20. Functional insufficiency of the pancreas and the metabolic activity of the microbiota in cystic fibrosis adults patients.
    Vinokurova LV, Baimakanova GE, Krasovsky SA, Silvestrova SY, Dubtsova EA, Varvanina GG, Bordin DS.
    Ter Arkh; 2018 Nov 22; 90(10):84-88. PubMed ID: 30701801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.